Crinetics Pharmaceuticals Inc (CRNX)
EBITDA Margin
-1206.92%
TTM · Period ending:
CRNX EBITDA Margin
Latest reported-1206.92%period ending
Latest reported-1206.92%period ending
CRNX TTM EBITDA Margin (-9901.30% → -1206.92%)
TTM ebitda margin
High-resolution chart · PNG
CRNX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -1,206.9243% | |
| -2,723.3549% | |
| -5,993.3342% | |
| -27,323.3225% | |
| -26,321.2644% | |
| -42,765.2632% | |
| -28,452.6468% | |
| -26,530.4139% | |
| -18,539.9278% | |
| -11,862.9686% | |
| -5,318.4899% | |
| -4,199.64% | |
| -3,781.5267% | |
| -4,066.7445% | |
| -3,439.6242% | |
| -2,913.8856% | |
| -2,898.537% | |
| -2,813.7087% | |
| -9,901.2987% |